Literature DB >> 1382473

PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity.

M S Qui1, S H Green.   

Abstract

Expression of oncogenic ras in PC12 cells causes neuronal differentiation and sustained protein tyrosine phosphorylation and activity of extracellular signal-regulated kinases (ERKs), p42erk2 and p44erk1. Oncogenic N-ras-induced neuronal differentiation is inhibited by compounds that block ERK protein tyrosine phosphorylation or ERK activity, indicating that ERKs are not only activated by p21ras but serve as the primary downstream effectors of p21ras. Treatment of PC12 cells with nerve growth factor or fibroblast growth factor results in neuronal differentiation and in a sustained elevation of p21ras activity, of ERK activity, and of ERK tyrosine phosphorylation. Epidermal growth factor, which does not cause neuronal differentiation, stimulates only transient (< 1 hr) activation of p21ras and ERKs. These data indicate that transient activation of p21ras and, consequently, ERKs is not sufficient for induction of neuronal differentiation. Prolonged ERK activity is required: a consequence of sustained activation of p21ras by the growth factor receptor protein tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382473     DOI: 10.1016/0896-6273(92)90033-a

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  121 in total

1.  Sustained signaling by phospholipase C-gamma mediates nerve growth factor-triggered gene expression.

Authors:  D Y Choi; J J Toledo-Aral; R Segal; S Halegoua
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  A dominant negative Egr inhibitor blocks nerve growth factor-induced neurite outgrowth by suppressing c-Jun activation: role of an Egr/c-Jun complex.

Authors:  Yechiel Levkovitz; Jay M Baraban
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

3.  Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway.

Authors:  M C Rouyez; C Boucheron; S Gisselbrecht; I Dusanter-Fourt; F Porteu
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  H-Ras signaling and K-Ras signaling are differentially dependent on endocytosis.

Authors:  Sandrine Roy; Bruce Wyse; John F Hancock
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

5.  A unique pathway for sustained neurotrophin signaling through an ankyrin-rich membrane-spanning protein.

Authors:  Juan Carlos Arévalo; Hiroko Yano; Kenneth K Teng; Moses V Chao
Journal:  EMBO J       Date:  2004-05-27       Impact factor: 11.598

6.  Global expression analysis identified a preferentially nerve growth factor-induced transcriptional program regulated by sustained mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) and AP-1 protein activation during PC12 cell differentiation.

Authors:  Steven Mullenbrock; Janki Shah; Geoffrey M Cooper
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

7.  Network-based analysis of multivariate gene expression data.

Authors:  Wei Zhi; Jane Minturn; Eric Rappaport; Garrett Brodeur; Hongzhe Li
Journal:  Methods Mol Biol       Date:  2013

8.  Expression of p27kip1 and Skp2 in the adult spinal cord following sciatic nerve injury.

Authors:  Shuxian Shi; Chun Cheng; Jian Zhao; Mengling Chen; Jing Qin; Shangfeng Gao; Aiguo Shen
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

9.  Temporal characteristics of activation, deactivation, and restimulation of signal transduction following depolarization in the pheochromocytoma cell line PC12.

Authors:  Amir H Nashat; Robert Langer
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

10.  Divergence in signaling pathways involved in promotion of cell viability mediated by bFGF, NGF, and EGF in PC12 cells.

Authors:  Takakazu Kawamata; Tomoko Yamaguchi; Kazuo Shin-ya; Tomokatsu Hori
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.